Hartaj Singh analyst OPPENHEIMER

Currently out of the existing stock ratings of Hartaj Singh, 112 are a BUY (93.33%), 1 are a SELL (0.83%), 7 are a HOLD (5.83%).

Hartaj Singh

Work Performance Price Targets & Ratings Chart

Analyst Hartaj Singh works at OPPENHEIMER with a stock forecast success ratio of 37.27% fulfilled within 205.8 days on average.

Hartaj Singh’s has documented 247 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GILD, Gilead Sciences at 12-Feb-2024.

Wall Street Analyst Hartaj Singh

Analyst best performing recommendations are on ONCT (ONCTERNAL THERAPEUTICS).
The best stock recommendation documented was for MRNA (MODERNA) at 4/15/2020. The price target of $43 was fulfilled within 2 days with a profit of $5.75 (15.44%) receiving and performance score of 77.18.

Average potential price target upside

ALXN Alexion Pharmaceuticals CATB Catabasis Pharmaceuticals GILD Gilead Sciences INO Inovio Pharmaceuticals LIFE aTyr Pharma MRNA Moderna REGN Regeneron Pharmaceuticals SBBP Strongbridge Biopharma plc SNSS Sunesis Pharmaceuticals UTHR United Therapeutics VIRX Viracta Therapeutics VRTX Vertex Pharmaceuticals SRPT Sarepta Therapeutics ELOX Eloxx Pharmaceuticals BMEA Biomea Fusion FSTX FStar Therapeutics ONCT Oncternal Therapeutics SPRB Spruce Biosciences  GANX Gain Therapeutics ATXS Astria Therapeutics CLLS Cellectis SA ICVX Icosavax NBSE NeuBase Therapeutics OPT Opthea Ltd ORTX Orchard Therapeutics PLC

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

205

$22.5 (12.33%)

2 years 11 months 8 days ago

3/5 (60%)

$35.09 (20.65%)

938

Hold

173

$-9.5 (-5.21%)

156

2 years 11 months 10 days ago

14/24 (58.33%)

$2.73 (1.60%)

682

Hold

190

$7.5 (4.11%)

194

3 years 2 months 9 days ago

9/11 (81.82%)

$34.41 (22.12%)

350

Hold

166

$-16.5 (-9.04%)

175

3 years 2 months 9 days ago

23/23 (100%)

$10.41 (6.69%)

828

Buy

155

3 years 3 months 6 days ago

7/7 (100%)

$36.79 (31.12%)

395

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Hartaj Singh is most bullish on?

Potential upside of $186.52 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Hartaj Singh is most reserved on?

Potential downside of -$7.34 has been obtained for INO (INOVIO PHARMACEUTICALS)

What Year was the first public recommendation made by Hartaj Singh?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?